Tumor News and Research

RSS

Researchers link aberrant 'microRNA' expression to human cancer

Over the past few years, scientists have discovered that a new class of genetic regulators called "microRNAs" influences normal human growth and development. Now, researchers have found that microRNAs also play an important role in human cancer. The findings are published in tomorrow's issue of the journal Nature (June 9).

8 Jun 2005

Novel targets found for the development of drugs to complement, or replace, statins

A team of investigators from the Uppsala Branch of the Ludwig Institute for Cancer Research (LICR) and Harvard Medical School has uncovered novel targets for the development of drugs that would potentially complement, or replace, statins in treating heart disease.

8 Jun 2005

U.S. Supreme Court overules states and makes marijuana for medicinal use illegal

A U.S. Supreme Court has decreed that the Federal Government has the power to prevent sick patients from smoking home-grown marijuana that a doctor recommended to relieve chronic pain. The 6 to 3 ruling by a divided court is a major setback for the medical use of marijuana.

6 Jun 2005

Test accurately predicts aggressiveness of breast cancer

A test that measures how quickly cells are dividing is an accurate way for doctors to predict the aggressiveness of breast cancer tumors, even among women with very early stages of the disease, researchers told the 2nd ESMO Scientific & Educational Conference (ESEC) in Budapest, Hungary.

6 Jun 2005

Gene linked to lower breast cancer risk

In a presentation at the 2nd ESMO Scientific & Educational Conference (ESEC) in Budapest, Hungary, Dr. Uwe Langsenlehner and colleagues from Medical University Graz in Austria showed that a specific genetic variation in a cytokine gene is associated with lower breast cancer risk.

6 Jun 2005

Genetically engineered virus has shown promise as a treatment for patients with colorectal cancer

A single injection of a genetically engineered virus has shown promise as a treatment for patients with colorectal cancer that has spread to the liver, according to preliminary results reported at the 2nd ESMO Scientific & Educational Conference (ESEC) in Budapest, Hungary.

6 Jun 2005

Suppression of growth hormone and related compounds beginning in early adulthood may delay the onset or progression of several types of cancer

A modest suppression of growth hormone and related compounds beginning in early adulthood may delay the onset or progression of several types of cancer, researchers from Wake Forest University School of Medicine and other centers reported today at ENDO 2005, the annual meeting of the Endocrine Society, in San Diego.

5 Jun 2005

Vaccine targets tumors where they live

Vaccine strategies are being designed to battle cancer, but their use for metastatic melanoma is a challenge.

3 Jun 2005

Scientists have uncovered the structure of a network of proteins that help regulate the life cycle of cells

Scientists at Memorial Sloan-Kettering Cancer Center (MSKCC) have uncovered the structure of a network of proteins that help regulate the life cycle of cells. Understanding the network's physical layout is an important step toward learning its precise function, and in finding ways to correct flaws in the system that could lead to cancer.

2 Jun 2005

Study links TNF to androgen deficiency in rheumatoid arthritis patients and suggest a novel pathway in inflammation

A protein involved in multiple cell functions, tumor necrosis factor (TNF) is perhaps best known for provoking destructive inflammation. Recently, drugs blocking the action of TNF have shown promise in the early treatment of rheumatoid arthritis (RA).

2 Jun 2005

Harmful chemicals may reprogram gene response to estrogen

New research shows that exposure to harmful chemicals and drugs during critical developmental periods early in life may actually "reprogram" the way certain genes respond to the female hormone estrogen. This genetic reprogramming may determine whether people with a genetic predisposition for a disease actually develop the disease.

1 Jun 2005

Early surgical removal of the spleen combined with antiangiogenic cancer therapy may halt the progression of leukemia

The research, published today in Blood, is the first to show the combination of two factors secreted from the environment of the spleen is important in the promotion of leukemia.

1 Jun 2005

Triple approach is promising against cancer cells

A trimodal treatment strategy combining chemotherapy, radiation therapy, and a protein kinase inhibitor is much more effective against cancer cells than any combination of only two treatment methods.

1 Jun 2005

New study linking pain relievers and breast cancer fails to convince experts

Research in recent years has consistently linked the use of aspirin and other anti-inflammatory pain relievers with a lower risk of colon cancer, but findings about the drugs' effect on breast-cancer risk have been very mixed with some studies suggesting that the pain relievers protect against breast cancer, while others have found no link.

1 Jun 2005

Shorter course of 8 gray radiotherapy effective for palliation of painful bone metastases

A single treatment of 8 gray (Gy--a unit of measure of absorbed radiation dose) of radiation appears to be as effective in palliating painful bone metastases as the current U.S. standard treatment course of 30 Gy delivered in 10 daily treatments, according to a new study in the June 1 issue of the Journal of the National Cancer Institute.

31 May 2005

Environment factors can interact with genetics to increase disease risk

31 May 2005

Is there a link between cell phones and brain tumors?

Is there a link between cell phones and brain tumors? Over the past 15 years, there has been growing concern about this possibility. Part of this concern stems from the fact that there are over one billion cell phone subscribers worldwide, and the number is increasing.

31 May 2005

New approach to inhibiting blood vessel growth or angiogenesis

A manmade protein with a tail of amino acids delivered to target cells can dramatically reduce blood vessel growth that obstructs vision or feeds a tumor, researchers have found.

31 May 2005

Targepeutics issued new U.S patent

Targepeutics has announced the issuance of U.S. Patent No. 6,884,603 for its genetically modified, mutated Interleukin 13 (IL-13) technology platform for the treatment of malignant glioma, a brain tumor (17,500 people annually; $200 million annual market).

31 May 2005

Exposure to pharmaceutical estrogen during fetal development can permanently "reprogram" tissue in a way that determines whether tumors will develop in adulthood

Researchers at The University of Texas M. D. Anderson Cancer Center may have uncovered the reason why some people who are genetically predisposed to hormone-dependent cancers develop the disease as an adult, while others who are similarly susceptible don't.

30 May 2005

Tumor News and Research

Researchers link aberrant 'microRNA' expression to human cancer

Novel targets found for the development of drugs to complement, or replace, statins

U.S. Supreme Court overules states and makes marijuana for medicinal use illegal

Test accurately predicts aggressiveness of breast cancer

Gene linked to lower breast cancer risk

Genetically engineered virus has shown promise as a treatment for patients with colorectal cancer

Suppression of growth hormone and related compounds beginning in early adulthood may delay the onset or progression of several types of cancer

Vaccine targets tumors where they live

Scientists have uncovered the structure of a network of proteins that help regulate the life cycle of cells

Study links TNF to androgen deficiency in rheumatoid arthritis patients and suggest a novel pathway in inflammation

Harmful chemicals may reprogram gene response to estrogen

Early surgical removal of the spleen combined with antiangiogenic cancer therapy may halt the progression of leukemia

Triple approach is promising against cancer cells

New study linking pain relievers and breast cancer fails to convince experts

Shorter course of 8 gray radiotherapy effective for palliation of painful bone metastases

Environment factors can interact with genetics to increase disease risk

Is there a link between cell phones and brain tumors?

New approach to inhibiting blood vessel growth or angiogenesis

Targepeutics issued new U.S patent

Exposure to pharmaceutical estrogen during fetal development can permanently "reprogram" tissue in a way that determines whether tumors will develop in adulthood

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News